Oct 19, 2026 08:10AM

Oct 5, 2026 06:40AM

Sep 30, 2026 08:31AM

Sep 24, 2026 01:26PM

Sep 12, 2026 04:00PM

Sep 9, 2026 07:28AM

Sep 8, 2026 01:25PM Jefferies: 'we can still see at least a +25-50% stock move if SRPT shows competitive/superior 6-month splicing/vHOT data'

Sep 8, 2026 10:53AM

Aug 5, 2026 04:35PM

Jul 28, 2026 06:44AM

Jul 27, 2026 08:30AM

Jul 8, 2026 05:08PM

Jul 1, 2026 06:58AM

Jun 30, 2026 11:00AM Mizuho Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)

Jun 30, 2026 08:30AM

Jun 18, 2026 06:11AM

May 6, 2026 04:46PM

Apr 17, 2026 06:46AM

Mar 27, 2026 07:00PM

Mar 26, 2026 06:39AM

Mar 25, 2026 04:04PM Barclays calls Sarepta Therapeutics (SRPT) data 'encouraging,' reiterates Equalweight rating

Mar 25, 2026 03:05PM

Mar 25, 2026 03:02PM

Mar 25, 2026 10:46AM

Mar 25, 2026 10:43AM

Mar 25, 2026 10:33AM

Mar 25, 2026 10:32AM

Mar 25, 2026 08:05AM Sarepta shares early clinical data from siRNA treatments for rare diseases

Mar 19, 2026 11:11AM

Mar 19, 2026 10:57AM

Mar 19, 2026 08:30AM

Mar 17, 2026 07:37AM

Mar 16, 2026 08:34AM

Mar 12, 2026 05:06PM

Mar 9, 2026 03:22PM Jefferies Reiterates Buy Rating on Sarepta Therapeutics (SRPT) following MDA conference 2026

Mar 3, 2026 03:44PM

Mar 3, 2026 12:00PM

Mar 2, 2026 06:47AM

Feb 26, 2026 08:30AM

Feb 25, 2026 04:45PM

Feb 24, 2026 09:08AM

Feb 4, 2026 08:30AM SAREPTA gets approval to test Huntington's disease treatment in humans

Jan 27, 2026 06:43AM

Jan 26, 2026 12:54PM

Jan 26, 2026 08:01AM

Jan 26, 2026 05:30AM

Jan 26, 2026 05:18AM

Jan 23, 2026 04:05PM

Jan 14, 2026 06:55AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)

Jan 14, 2026 04:39AM

483,192 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All